Corona: a well-cultivated virus for billionaires


From the blog of “Doctors Against Animal Experiments”, 19.05.2020

It feels like a time machine: genetic information was successfully decoded in a very short time, first trials on monkeys were promising, and soon the vaccine will be tested on humans.
Sounds familiar – in fact it is a report on SARS from 2003.


The article in the “German medical magazine” reported on the progress of vaccine development against SARS-CoV, the “first” coronavirus.

The virus family of Coronaviridae includes the currently rampant SARS-CoV-2 and the SARS-CoV-1, which was created in China in 2002.
At the time, this virus triggered a pandemic that killed nearly 800 people worldwide.

Here too, research was intensively carried out on therapy and, above all, vaccination.

If you take a closer look at the earlier data, this has a more than revealing effect: In 2010 (7 years after the outbreak of the pandemic) a vaccine was tested on mice, among other things. The animals showed only limited immunity, which even completely disappeared after 18 weeks.

In 2012, almost 10 years after the outbreak, vaccinated mice showed an antibody formation, but after infection with the virus also an autoimmune reaction of the lungs, i.e. the defense system was directed against its own tissue.

Research on a vaccine was discontinued shortly thereafter.
Reason: the virus no longer occurs. This makes us suspicious, because at this point the pandemic had been over for almost 10 years and all animal tests that had taken place shortly before were unsuccessful.
Was it perhaps more because the (animal-based) research simply did not progress and then an apology was sought to secretly drop the whole thing under the table?

corona Impfung peg

Christian Drosten, currently the best known virologist in Germany, wrote a report in 2003 that reads that the SARS virus, even if it disappears, can withdraw into animal reservoirs and from that reservoir … “in due course, an epidemic can arise … “

This also contradicts the credibility of the above statement – especially since MERS appeared in 2012, also a type of corona virus, for which no vaccination for humans exists to this day.

Logically speaking, research should have continued from there at the latest.

The report also says that a vaccine can be expected in 1 to 2 years at the earliest, and that it is “encouraging” that the virus is well cultivated (!!!) and that there are already vaccines against animal corona viruses, that infect birds or dogs, for example.

This clearly shows that animal experiments do not make any sense in research – because a vaccine for humans against the first SARS virus still does not exist today, 17 years later.

Now it is pretended that animal experiments are inevitable to find a vaccine, and as in the past, the world is promised full rescue.

With all of this, in addition to the massive and unacceptable ineffectiveness, another problem is revealed: animal experiments are time and thus (tax) money wasters.

At the same time, there are promising insights from human-focused research: using human cells, mini-organs (organoids) can be grown in the laboratory, on which both the route of infection and the effects of possible medicines can be traced – which costs only a fraction of the time and money that is sunk into the animal testing system.

The importance of this human-based research is demonstrated, for example, by the fact that the respected Max Planck Institute for Infection Biology in Berlin describes its lung organoids as an “ideal test system”.

Promising, fast, cheap and human-relevant results compared to non-transferable, expensive, lengthy and painful animal experiments: we should learn from the past and
put the focus on the research methods of the future.


My comment: Just today I read in an article that the full approval process for vaccines usually takes more than a decade, and even the most optimistic experts – including Dr. Anthony Fauci, who has become the public face of US Covid-19 policy- has said that a shot will only be completed in another year, and even up to 18 months.

When a vaccine is launched in the middle of a pandemic, extensive safety reviews need to be sacrificed for efficiency – a compromise that can be catastrophic, like the 2009 Pandemrix swine flu vaccine, which caused permanent brain damage in over 1,000 British patients.

The parallels between Covid-19 and that epidemic are ominous – wildly inflated death predictions had spooked the UK government into approving Pandemrix without sufficient safety data – and it surely won’t help Americans’ trust in this vaccine that Trump’s “vaccine czar” Moncef Slaoui ran GlaxoSmithKline’s vaccine division during the swine flu debacle.

Slaoui earned $3 million on Monday alone from Moderna, which is still considered the leading candidate in the vaccine race, even though the drug company has never brought a vaccine to market.

After hyping up what were essentially meaningless preliminary results, Moderna’s stock shot up 25 percent, bringing his holdings to over $10 million.

A vaccine produced at Oxford University hasn’t fared much better, with all six rhesus monkeys who received the shot becoming infected anyway – despite a preliminary report that tried to spin the failure as representing “some” success.

I cannot understand why anyone can be in favor of the next COVID-19 untested, unsafe vaccinations under those circumstances unless they want to die and don’t care what’s actually in the vaccination.

My best regard to all, Venus

One thought on “Corona: a well-cultivated virus for billionaires”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s